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Abstract
 
The immunoreceptor tyrosine-based activation motifs (ITAMs) in the CD3 chains associated
with the T cell receptor (TCR) are crucial for TCR signaling. To probe the role of the
 
CD3
 
 
 
–ITAM in T cell development, we created knock-in mice in which the CD3
 
 
 
 chain of
 
the TCR complex is replaced by a mutant signaling-deficient CD3
 
 
 
 chain, lacking the
CD3
 
 
 
–ITAM. This mutation results in considerable impairment in positive selection in the
polyclonal TCR repertoire. When CD3
 
 
 
–
 
 
 
ITAM mice are crossed to mice expressing trans-
genic F5 TCRs, their thymocytes are completely unable to perform positive selection in vivo
in response to intrathymic ligands. Also, the in vitro positive selection response of double-pos-
itive (DP) thymocytes with F5–CD3
 
 
 
–
 
 
 
ITAM mutant receptors to their agonist ligand and
many of its variants is severely impaired or abrogated. Yet, the binding and dissociation con-
stants of agonist ligands for the F5 receptor are not affected by the CD3
 
 
 
–
 
 
 
ITAM mutation.
Furthermore, DP thymocytes with mutant receptors can respond to agonist ligand with normal
antigen sensitivity and to normal levels, as shown by their ability to induce CD69 up-regula-
 
tion, TCR down-regulation, negative selection, and ZAP70 and c-Jun NH
 
2
 
-terminal kinase
activation. In sharp contrast, induction of extracellular signal-regulated kinase (ERK) activation
and linker for activation of T cells (LAT) phosphorylation are severely impaired in these cells.
Together, these findings underscore that intrinsic properties of the TCR–CD3 complex regu-
late selection at the DP checkpoint. More importantly, this analysis provides the first direct ge-
netic evidence for a role of the CD3
 
 
 
–ITAM in TCR-driven thymocyte selection.
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Introduction
 
The CD3 chains associated with the TCR contain shared
and semi-conserved immune receptor tyrosine-based acti-
 
vation motifs (ITAMs)
 
*
 
 that link the TCR to the down-
stream signaling machinery by binding to key adaptor mol-
ecules and enzymes (1, 2; for reviews, see references 3 and
4). All of the signaling capacity of the TCR is contained
within the CD3 chains (CD3
 
 
 
, -
 
 
 
, -
 
 
 
, and -
 
 
 
). CD3
 
 
 
, -
 
 
 
,
and -
 
 
 
 polypeptides each contain one and CD3
 
 
 
 contains
 
three ITAMs (YxxL/Ix
 
6–8
 
YxxL/I) within their cytoplas-
mic domains, and are assembled in each TCR complex as
3 dimers: 
 
  
 
, 
 
  
 
, and 
 
  
 
. Together, these dimers contribute
10 ITAMs to the TCR complex, and antigen receptor
triggering results in phosphorylation of the tyrosine resi-
dues within the ITAMs by activated Src family kinases.
The phosphorylation of ITAM tyrosine residues represents
one of the earliest events in the TCR signaling cascade,
permitting the recruitment of a number of SH2-domain–
containing signaling proteins, of which the most crucial
one is the Syk protein tyrosine kinase (PTK) ZAP70. SH2-
domain–containing signaling proteins recruited to the
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TCR complex are subsequently phosphorylated and acti-
vated, allowing binding of additional signaling molecules
to occur (for reviews, see references 3 and 5). It is clear
therefore that the ITAMs are crucial for initiating TCR-
mediated signaling, but the exact function of ITAM multi-
plicity remains to be elucidated.
The presence of multiple ITAMs within a single TCR
complex may have several functions (for a review, see ref-
erence 6). CD3 components may make quantitative and
partially overlapping contributions to TCR signaling, as
the many ITAMs may provide the capacity to amplify sig-
nals required for reaching the activation threshold (2)
through low affinity/avidity TCR–MHC interactions. In
support of this view, a direct correlation between the num-
ber of CD3
 
 
 
–ITAMs and the efficiency of both positive
and negative selection was observed in one particular
TCR-transgenic model (7). Alternatively, supported by a
number of studies (1, 8, 9) the individual ITAMs may
function in signal discrimination. This may be the result of
micro-heterogeneity in the amino acids flanking the phos-
photyrosine residues within the ITAMs, which are able to
specify interactions with distinct SH2-domain–containing
signaling proteins (10, 11). Indeed, in vitro studies indicate
that ITAMs derived from different CD3 chains bind pref-
erentially to distinct signaling molecules, or bind with vary-
ing affinities (12–17; for a review, see reference 4). Cer-
tainly, the different hypotheses concerning the role of
ITAM multiplicity are not mutually exclusive, and signal
discrimination may be the result of quantitative differences
in signal strength (6,
 
 
 
8, 18).
Most in vivo studies on the possible role of ITAM multi-
plicity in TCR signal specification have been performed on
CD3
 
 
 
–ITAMs (2, 7, 8, 19, 20), and one on CD3
 
 
 
–ITAM
(21). In the present study, we addressed whether the
CD3
 
 
 
–ITAM performs a role in TCR signal specification.
From our earlier studies in CD3
 
 
 
-deficient mice, it is clear
that the CD3
 
 
 
 chain is required for 
 
 
 
-selection of DN thy-
mocytes, most likely as a consequence of its crucial role in
pre-TCR assembly (22). CD3
 
 
 
-deficient mice therefore
barely produce CD4
 
 
 
CD8
 
 
 
 (double positive [DP]) thy-
mocytes and mature T cells, precluding an evaluation of
the possible role of CD3
 
 
 
 at later stages of development.
Moreover, as assembly of the mature TCR complex is se-
verely hampered by absence of CD3
 
 
 
 (23), the exact con-
tribution of CD3
 
 
 
 to selection of the TCR repertoire and
mature T cell function is difficult to assess. Yet, when both
the block in 
 
 
 
-selection and TCR levels on DP thy-
mocytes are rescued in CD3
 
 
 
-deficient mice, through in-
troduction of transgenic F5 TCRs, positive selection can
still not occur (see Results). This suggests that CD3
 
 
 
 con-
tributes specific signals required for positive selection, and
this possibility was tested directly in knock-in mice ex-
pressing CD3
 
 
 
 chains lacking only the CD3
 
 
 
–ITAM (23),
leaving intact the contribution of CD3
 
 
 
 to assembly of the
TCR–CD3 complex. These mice therefore have normal
TCR expression levels, and we here show that this muta-
tion profoundly affects positive selection, but not negative
selection at the DP checkpoint.
 
During thymocyte selection, signals triggered by the
TCR specify cell fate of immature thymocytes at the DP
stage. Under certain conditions, TCR signals trigger apop-
tosis, resulting in negative selection of those DP thy-
mocytes with self-reactive TCRs. Paradoxically, TCR sig-
nals can also trigger survival and further differentiation in
DP thymocytes (positive selection) (for a review, see refer-
ence 24), and one of the central questions in the develop-
mental biology of T cells is how the distinction between
positive and negative selection signals is made. Both quan-
titative and qualitative models have been proposed, and
models that merge the two concepts, such that quantitative
differences in the strength of the stimulus can result in
qualitative differences in the signals transduced (18; also re-
viewed in reference 6). In a strictly quantitative model,
strong activation signals result in apoptosis (negative selec-
tion), and weaker signals in positive selection (25). The mi-
togen-activated protein kinase (MAPK) cascades have been
suggested to be the “instruments” for dictating the qualita-
tively distinct biological outcomes that may result from
quantitative differences in signal strength. Specifically, the
ERK cascade has been implicated in positive selection (26–
35), and the c-Jun NH
 
2
 
-terminal kinase (JNK) and p38
cascade in negative selection (18, 30, 36, 37). While it is to
be expected that the decision between positive and nega-
tive selection is the consequence of engagement of differ-
ent signaling pathways, it remains to be defined how indi-
vidual TCRs link to distinct cascades. We here present
evidence for a contribution of the signaling moiety of one
of the TCR-associated CD3 chains, the CD3
 
 
 
–ITAM, to
signal specification at the DP checkpoint.
 
Materials and Methods
 
Mice.
 
Mice were maintained under specific pathogen-free
conditions in the animal colony of the Netherlands Cancer Insti-
tute and analyzed at 6–8 wk of age unless indicated otherwise.
CD3
 
 
 
-deficient, CD3
 
 
 
–
 
 
 
ITAM mutant, and F5-recombination
activating gene (RAG)
 
 
 
/
 
 
 
 mice have been described in detail
elsewhere (22, 23, 38). In all experiments in which the F5-trans-
genic TCR is introduced onto wild-type (WT) or mutant mice,
the RAG-deficient background is used, to prevent expression of
endogenous TCRs.
 
Flow Cytometry.
 
Single cell suspensions were prepared in
PBA (1
 
  
 
PBS, 1% BSA, 0.02% NaN
 
3
 
), aliquoted into wells of a
96-well plate (10
 
5
 
–10
 
6
 
 cells/well), and pelleted at 200 
 
g
 
 for 2 min.
Cells were resuspended in 20 
 
 
 
l of anti-Fc
 
 
 
RII/III (clone 2.4G2;
final concentration 1 
 
 
 
g/ml) to reduce nonspecific staining, and
incubated for 10 min at 4
 
 
 
C. Staining for cell-surface antigen ex-
pression was performed at saturating mAb concentrations for 20–
30 min at 4
 
 
 
C. Cells were washed twice in 100 
 
 
 
l of PBA and in-
cubated with second-step reagent if necessary. Finally, all samples
were washed twice and resuspended in 100 
 
 
 
l of PBA. Cells
were analyzed on a Becton Dickinson FACSCalibur™. Forward-
and side-scatter gating and/or propidium iodide (PI) gating was
used to exclude dead cells from the analysis.
Biotinylated, FITC-, PE-, or allophycocyanin (APC)-conju-
gated antibodies specific for murine CD4 (clone RM4–5), CD5
(clone 53–7.3), CD8
 
 
 
 (clone 53–6.7), CD8
 
 
 
 (clone 53–5.8),
CD24 (HSA; clone M1/69), CD69 (clone H1.2F3), and TCR
 
  
3
 
Haks et al.
 
(clone H57–597) were obtained from BD PharMingen. R-PE
anti–mouse CD4 (clone CT-CD4) was purchased from Caltag.
Where appropriate, streptavidin (SA)-Tricolor or SA-PE (Caltag)
were used as second-step reagents.
Preparation of PE- or APC-conjugated H-2D
 
b
 
-tetramers con-
taining the nucleoprotein peptide (NP
 
366–374(NT)
 
; ASNENM-
DAM) of the influenza A virus strain A/NT/60/68 has been de-
scribed previously (39).
 
Fetal Thymic Organ Cultures.
 
Fetal thymic lobes were pre-
pared from mice at day 14 of gestation. They were cultured on
filter discs on gelfoam in Iscove’s modified Dulbecco’s medium
supplemented with 10 mM Hepes buffer, nonessential amino ac-
ids, 4 mM 
 
l
 
-glutamine, penicillin, streptomycin (all from GIBCO
BRL), 5 
 
 
 
 10
 
 
 
5
 
 M 2-
 
 
 
-mercaptoethanol, and 20% fetal calf se-
rum. At the indicated time-points, single cell suspensions were
prepared and thymocytes were examined by FACS
 
®
 
 analysis.
 
T Cell Proliferation.
 
Lymph node T cells (2 
 
 
 
 10
 
5
 
 cells/well)
were prepared and cultured as described (23) with graded con-
centrations of the nominal peptide ASNENMDAM or a negative
control peptide ASNANMDAM (this peptide variant lost H-2D
 
b
 
binding capacity) in a total volume of 200 
 
 
 
l complete medium
(Iscove’s modified Dulbecco’s medium [GIBCO BRL] supple-
mented with 10% FCS [PAA Laboratories GmbH], 2 
 
 
 
 10
 
 
 
5
 
 M
2-mercaptoethanol [Merck], 100 U/ml penicillin, and 100 
 
 
 
g/
ml streptomycin) in a round-bottomed microtiter well at 37
 
 
 
C.
After 3 d, cultures were pulsed with 0.5 
 
 
 
Ci/well [
 
3
 
H]thymidine
for 18 h and thymidine incorporation was measured by liquid
scintillation counting. All assays were performed in triplicate and
SDs were 
 
 
 
10% of the mean.
 
MHC–TCR Dissociation Rates.
 
Determination of TCR–
MHC off-rates were performed essentially as described previ-
ously (40). Briefly, thymocytes were stained with PE-conjugated
H-2D
 
b
 
-ASNENMDAM-tetramers for 20 min at 4
 
 
 
C, washed
once in PBA (1   PBS, 1% BSA, 0.02% NaN3), and subse-
quently, an excess of homologous unlabeled H-2Db monomers
(10  M) was added. Decay of H-2Db tetramer staining was ana-
lyzed by flow cytometry on electronically gated DP thymocytes
at indicated times and plotted as the percentage of maximum
staining as follows: (FIexp   FI0)/(FImax   FI0)   100%. Simulta-
neous staining of H-2Db tetramers and 10  M unlabeled homol-
ogous H-2Db monomers prevents the binding of tetrameric
MHCs (not shown).
TCR Down-regulation. Total thymocytes (105 cells/well) were
stimulated with indicated amounts of soluble H-2Db-ASNENM-
DAM-tetramers in a total volume of 200  l complete medium in
a flat-bottomed microtiter well at 37 C. After 1 or 5 h, cells were
stained with antibody combinations allowing gating on the
CD4 CD8  T cells and simultaneously determining the levels of
TCR  expression. 100% value corresponds to the mean fluores-
cence of the TCR  staining on unstimulated DP thymocytes.
In Vitro Thymocyte Stimulation Assays. DP thymocytes were
purified by panning total thymocytes on anti-CD4 (20  g/ml)
coated petri dishes twice, and purity was  98%, as determined
by flow cytometry. TCR levels were equal on the CD69-nega-
tive sorted DP cells (see Figs. 4 B and 5 A). Stimulation of DP
thymocytes in dispersed culture were essentially performed as de-
scribed (41), with the exception that the LEC B cell lymphoma
line (42, 43) was used as a source of antigen presenting cells.
Briefly, graded concentrations of the immuno-dominant peptide
of the influenza A virus ASNENMDAM and a panel of 8 variant
ligands were added individually to purified DP thymocytes (1  
105 cells/well) in the presence of LEC cells (0.5   105 cells/well)
in a total volume of 200  l complete medium in a flat-bottomed
microtiter well at 37 C. After 18–24 h of culture, analysis of
CD69 up-regulation, CD4 and CD8 expression, and thymocyte
cell death by propidium iodide staining was performed. It should
be noted that the absolute numbers of CD8 cells (confirmed to
express both CD8  and CD8 ) increased in a peptide-depen-
dent fashion, and therefore does not merely represent selective
survival.
Because some reactivity against the LEC cell line was observed
without adding peptide, and because some F5–WT DP thy-
mocytes developed overnight into CD8 single-positive (SP) thy-
mocytes without exposure to any exogenous added peptide,
CD69 expression, generation of CD8 SP thymocytes, and cell
death of DP thymocytes are expressed as “% response”. Calcula-
tions were performed as described (41), by correcting for this
background by subtraction of the response obtained with LEC
cells without peptide added. “100% response” represents the
CD69 up-regulation by all cells, the maximal induction of CD8
SP thymocytes by the nominal peptide ASNENMDAM in the
experiment, or the maximal cell death induced by the agonist
peptide ASNENMDAM in the experiment. As CD69 expression
on DP thymocytes was analyzed by flow cytometry only on via-
ble cells, and because a significant proportion of the DP thy-
mocytes died during the overnight suspension culture without
(and to a greater extent with) peptide exposure, we corrected for
this by assuming that all DP thymocytes induced to die by pep-
tide exposure also expressed CD69 (expression of CD69 precedes
both positive and negative selection). Calculation: percentage
CD69 induced on DP thymocytes   (percentage viable DP
cells   percentage CD69 measured by flow cytometry)   (per-
centage of dead DP cells).
Immunoblotting and Kinase Activity Assays. TCR stimulation
of purified DP thymocytes was performed by incubating cells
with 10  g/ml biotinylated anti-TCR  (clone H57–597) mAbs
for 20 min at 4 C followed by cross-linking with 20  g/ml Avi-
din D (Vector Laboratories) at 37 C, or by incubating with 5  g/
ml ASNENMDAM peptide together with 10  g/ml anti-CD28
(clone 37.51) at 37 C for the times indicated. Subsequently,
whole-cell lysates were prepared in lysis buffer (1% NP-40, 20
mM Tris-HCl pH 8.0, 140 mM NaCl, 10% glycerol, 2 mM
EDTA, 20 mM NaF, 1 mM Na3VO4, and a cocktail of protease
inhibitors [Boehringer]) and proteins were resolved by SDS-
PAGE and transferred onto nitrocellulose membranes. Kinase
activation was analyzed by immunoblotting using anti-phos-
phoERK (New England Biolabs, Inc.) or anti-phosphoTyrosine
(clone 4G10; Upstate Biotechnology) antibodies, followed by
horseradish peroxidase–conjugated secondary antibodies (Dako),
and developing the blots by chemiluminescence (Pierce Chemi-
cal Co.). Total levels of ERK and linker for activation of T cells
(LAT) expression were measured by reprobing the blots with
anti-ERK (Santa Cruz Biotechnology, Inc.) or anti-LAT (Up-
state Biotechnology, Inc.) antibodies. JNK activity was deter-
mined by incubating cell extracts (25  g) with 10  g GST-c-Jun
bound to glutathione-agarose beads in dilution buffer (25 mM
Hepes, pH 7.6, 2.5 mM MgCl2, 0.05 mM EDTA, 0.025% Triton
X-100, 0.5 mM DTT, 0.1 mM Na3VO4, 20 mM  -glycerophos-
phate, 4 mM p-nitrophenyl phosphate, and a cocktail of protease
inhibitors) overnight at 4 C. Subsequently, precipitates were
washed five times in washing buffer (20 mM Hepes, pH 7.6, 50
mM NaCl, 2.5 mM MgCl2, 0.1 mM EDTA, 0.05% Triton
X-100, 0.1 mM Na3VO4, 20 mM  -glycerophosphate, 4 mM
p-nitrophenyl phosphate) and resuspended in 30  l kinase buffer
(20 mM Hepes, pH 7.6, 20 mM MgCl2, 2 mM DTT, 0.1 mM
Na3VO4, 20 mM  -glycerophosphate, 4 mM p-nitrophenyl4 Thymocyte Selection in Mice Lacking the CD3 –ITAM
phosphate) containing 20  M ATP and 3  Ci  -[32P]ATP for 20
min at 37 C. After four washes in cold washing buffer, GST-
c-Jun was eluted in Laemmli buffer and resolved on 12% SDS-
PAGE. The phosphorylated GST-c-Jun fusion protein was visu-
alized and quantified using a PhosphorImager. Total levels of
JNK were measured by immunoblotting with anti-JNK1/2 anti-
bodies (Santa Cruz Biotechnology, Inc.).
Detection of ZAP70 Tyrosine Phosphorylation. TCR stimula-
tion of purified DP thymocytes was performed in stimulation
media (RPMI containing 1 mM vanadate and 20 mM HEPES
pH 7.0). Cells were incubated at 108 cells/ml with 150  g/ml
anti-TCR  (clone H57–597) antibodies for 15 min on ice. Sub-
sequently, cells were washed twice in stimulation media followed
by cross-linking with 100  g/ml goat anti-hamster (ICN Bio-
medicals/Cappel) at 37 C for the indicated times. After stimula-
tion, cells were lysed at 107 cells/ml in Triton X-100 lysis buffer
for 20 min on ice and the detergent extracts were clarified for 10
min at 14,000 rpm as described (44). For immunoprecipitations,
lysates were incubated for 2 h with anti-ZAP70 antibodies pread-
sorbed to Protein A sepharose beads. The beads were washed
three times in lysis buffer following which the immune com-
plexes were eluted by boiling for 5 min in SDS sample buffer.
Immune complexes were resolved by SDS-PAGE, transferred to
Immobilon-P (Millipore) membranes, and immunoblotted with
anti-phosphoTyrosine antibodies (clone 4G10; Transduction
Laboratories) or rabbit anti-ZAP70 antibodies. Bound antibodies
were detected by incubation with either anti–mouse-horseradish
peroxidase (HRP) or protein A-HRP, followed by enhanced
chemiluminecence (Renaissance; NEN Life Science Products).
Results
Loss of the CD3  -ITAM Impairs Positive Selection. Mice
lacking the CD3  chain of the TCR-CD3 complex have a
severe defect in  -selection, and therefore produce few DP
thymocytes (22; and Fig. 1 A, top). This is presumably a
consequence of defective pre-TCR assembly (unpublished
data), and precludes assessment of whether the CD3  chain
has any role in selection at the DP stage of thymocyte de-
velopment. As the block in  -selection in various models
of defective pre-TCR function can be bypassed by intro-
duction of transgenic TCRs (45), we explored whether this
might also apply to CD3 -deficient pre-TCRs. To this
end, F5 TCR   transgenes (38) were introduced into
CD3  null mutant mice, and mice were also crossed to the
RAG-1–deficient background, to prevent expression of
endogenous TCR chains (Fig. 1). F5 TCRs are specific for
the dominant NP epitope of influenza A virus, which is
recognized in association with H-2Db, and therefore skew
positive selection toward the CD8 compartment (38).
When crossed to RAG-1–deficient mice, positive selection
of CD8 cells is virtually absolute for WT F5 TCRs (F5–
WT; Fig. 1 A, bottom), with hardly any cells progressing to
the CD4 compartment.
Introduction of F5-transgenic TCRs into CD3 -defi-
cient mice crossed to the RAG /  background (F5–
CD3  /  mice) clearly has the ability to bypass the  -selec-
tion defect: thymic cellularity is partially restored, the
percentage of DP cells reaches normal levels, and the DN
compartment is reduced in size (Fig. 1 A, bottom panel).
These findings confirm earlier studies on restoration of
 -selection by transgenic TCRs (45), and presumably re-
flect that    and    TCRs can partially replace pre-TCRs
in  -selection. Also TCR levels in the DP compartment of
F5–CD3  /  mice are considerably increased when com-
pared with the CD3  /  mice (Fig. 2 A), as is CD5 ex-
pression (Fig. 2 B), which is up-regulated during the DN
to DP transition. Yet, important differences remain, as F5–
CD3  /  mice completely lack CD8 SP cells in the thy-
mus (Fig. 1 A, bottom), as well as in the periphery (Fig. 1
B, bottom), and lag behind in down-regulating CD24 (Fig.
2 B). These results therefore suggest a crucial role for the
CD3  chain during positive selection.
As the CD3  protein is clearly required for efficient cell
surface expression of the mature TCR (22, 23; Fig. 2 A),
Figure 1. The ITAM of the CD3  chain plays a major role in thy-
mocyte selection. Total thymocytes (A) and lymph node cells (B) from
6–8-wk-old WT, CD3  / , CD3 – ITAM, F5–WT, F5–CD3  / ,
and F5– ITAM  mice were monitored for the expression of CD4 versus
CD8. The percentage of cells within each quadrant is indicated. The ab-
solute number of thymocytes and lymph node cells detected in the differ-
ent genotypes is depicted above the corresponding dot display.5 Haks et al.
besides endowing this receptor with signaling capacity,
quantitative or qualitative causes for the positive selection
defect in F5–CD3  /  mice must be distinguished. DP
thymocytes of knock-in mice expressing an ITAM signal-
ing-deficient CD3  chain exhibit normal cell surface levels
of the TCR  protein (23; Fig. 2 A), allowing an opportu-
nity to discriminate between these two options. Therefore,
CD3 – ITAM mice were crossed to F5–RAG /  mice.
Strikingly, loss of only the CD3 –ITAM completely abol-
ished positive selection in F5–RAG /  mice (further re-
ferred to as F5– ITAM  mutants), as no CD8 SP thy-
mocyte subset could be detected (Fig. 1 A, bottom). This
observation documents that the endogenous thymic pep-
tide repertoire is unable to trigger positive selection signals
through F5– ITAM  mutant TCRs. Further corrobora-
tion of this profound defect is seen in the peripheral T cell
compartment: lymph nodes from F5– ITAM  mutant
mice completely lack T cells (Fig. 1 B, bottom panel),
whereas F5–WT mice have the expected skewed presence
of mature CD8 T cells.
In contrast to F5– ITAM  mice, CD3 – ITAM mu-
tants with a polyclonal TCR repertoire have normal thy-
mic cellularity, and the distribution of the CD4 and CD8
coreceptors over the different thymic and lymph node
populations is also comparable to WT mice (Fig. 1, A and
B, top). At face value, it therefore appears that thymocyte
selection of a polyclonal repertoire is unaffected by absence
of a CD3 –ITAM. We argued, however, that the snapshot
phenotypical evaluation of selection taken in adult mice
may not accurately reflect the dynamics of selection: in a
pool of DP thymocytes engaged in a wide range of diverse
signaling events, the consequences of a mutation in a single
signaling molecule might easily be obscured. In a dynamic
evaluation of selection, on the other hand, possible distur-
bances may be revealed. We therefore compared the ability
of WT and CD3 – ITAM fetal thymocytes from mice
with a polyclonal TCR repertoire to perform positive se-
lection in fetal thymic organ cultures (FTOCs), and clear
differences emerged. First, the frequency of thymocytes ex-
pressing high levels of TCR was reduced at least twofold in
the CD3 – ITAM mutants (Fig. 3 A), at all time points
tested (Fig. 3 B). Second, the percentage of SP cells gener-
ated is decreased, with a concomitant increase in DP thy-
mocytes (Fig. 3 C). Thus, positive selection occurs less effi-
ciently in multiple TCRs lacking the CD3 –ITAM. At the
same time, compensatory effects likely related to TCR af-
finity and off-rate clearly can occur, as SP do accumulate in
a polyclonal TCR repertoire (Fig. 1). Nevertheless, for
some TCRs, represented by the F5, an intact repertoire of
ITAMs is required (Figs. 1 and 3).
Together, these findings support a role for the CD3 –
ITAM at the DP checkpoint of thymocyte selection for
some TCRs. Further dissection of the possible contribution
of CD3 –ITAM requires experiments with a transgenic
TCR, such that interactions of the mutant and WT recep-
tors with defined ligands can be compared. The remainder
of this study is therefore performed with F5– ITAM  mu-
tant DP thymocytes.
Figure 2. Analysis of TCR-, CD5-, and CD24- expression on DP thy-
mocytes. Expression of cell surface TCR  (A), CD5 and CD24 (B) (gray),
or an irrelevant mAb (white) was analyzed within the electronically gated
CD4 CD8  DP compartment derived from 6–8-wk-old WT, CD3  / ,
CD3 – ITAM, F5–WT, F5–CD3  / , and F5– ITAM  mice.6 Thymocyte Selection in Mice Lacking the CD3 –ITAM
Loss of the CD3 –ITAM Does Not Affect Ligand Interac-
tion, TCR Down-regulation, or CD69 Up-regulation. Why
might F5– ITAM  mutant receptors not respond to the
endogenous peptide repertoire in the thymus by triggering
the positive selection program (Fig. 1)? Two overall possi-
bilities need to be distinguished: either the CD3 –ITAM
provides prerequisite signaling information for positive se-
lection of F5 TCRs and some other TCRs (Fig. 3), or F5–
 ITAM  mutant receptors fail to bind to peptide ligands,
or bind with insufficient affinity. To formally exclude any
(highly unlikely) effects of the CD3 –ITAM mutation on
peptide-ligand binding, we first compared the binding
characteristics of F5–WT and F5– ITAM  mutant recep-
tors to their nominal ligand. We also addressed the possibil-
ity that the CD3 –ITAM mutation selectively destroys
some responses (i.e., positive selection), but not others in
DP thymocytes. If so, this would then support a model in
which the CD3 –ITAM contributes to signal specification.
The F5 TCR recognizes the ASNENMDAM epitope of
the influenza A nucleoprotein, as published previously (38)
and illustrated in Fig. 4 A, in the proliferative response of
F5–WT lymph node T cells to this peptide. To address
whether the CD3 –ITAM mutation has any effect on AS-
NENMDAM binding, we compared binding of MHC-
ASNENMDAM-tetramers to F5–WT and F5– ITAM 
mutant receptors in the CD69-negative DP compartment.
As expected, we found tetramer binding to be entirely
overlapping (Fig. 4 B). Furthermore, the F5–WT and F5–
 ITAM  mutant TCRs have comparable off-rates for this
ligand (Fig. 4 C): if anything, binding of the nominal
epitope to the F5– ITAM  mutant receptor has a some-
what slower off-rate than that for the F5–WT receptor.
We then asked whether we could identify any parame-
ters which would illustrate that F5– ITAM  mutant re-
ceptors cannot only bind to their ligand, but also respond
to bound ligand by triggering appearance of activation
markers. Importantly, both the F5–WT and the F5–
 ITAM  mutant receptor can respond to the ASNENM-
DAM epitope, as shown by the observation that DP thy-
mocytes from both up-regulate CD69 when activated by
ASNENMDAM (Fig. 4 D; for the actual CD69 expres-
sion data on F5– ITAM  DP thymocytes, see Fig. 5 A),
and do so with comparable sensitivity, in agreement with
their similar binding kinetics. Induction of this early
activation marker is therefore not affected by the
CD3 –ITAM mutation. We also tested the effects of
ASNENMDAM binding on internalization of F5–WT
and F5– ITAM  mutant TCRs. TCR down-modulation
represents another early marker for response to TCR trig-
gering, although its physiological relevance is unclear. We
previously showed, in mice with a polyclonal TCR reper-
toire, that the CD3  chain is required for both anti-
CD3 - and PMA-triggered TCR down-regulation (23),
but the CD3 –ITAM is dispensable. When ligand-trig-
gered TCR internalization is compared between F5–WT
and F5– ITAM  mutant DP thymocytes, it is clear that
this ITAM is not required: down-modulation of TCR ex-
pression occurs with similar kinetics and to a comparable
extent in the F5–WT and F5– ITAM  mutant receptors
(Fig. 4 E).
Together, these findings document that F5– ITAM 
mutant receptors can both bind to and respond to the ago-
nist peptide for the F5 TCR, with equal binding kinetics
and antigen sensitivity. It is therefore very striking that F5–
 ITAM  mutant receptors cannot identify, among the
broad range of intrathymic peptides it interacts with in
vivo, any ligands at all that bind with appropriate kinetics
to allow positive selection to occur. These findings suggest
that lack of CD3  results in quantitative or qualitative dif-
ferences in signaling which, for F5 TCRs and at least for
some other (unidentified) TCRs (see Fig. 3), result in a se-
lective defect in positive selection.
Ex Vivo Triggering of F5– ITAM  Mutant Receptors Can
Induce Negative Selection, but Positive Selection Is Severely Im-
paired or Abrogated. Upregulation of CD69 precedes both
positive and negative selection in DP thymocytes (41; and
references therein). The observation that CD69 up-regula-
tion was normal in thymocytes expressing F5– ITAM 
Figure 3. Positive selection occurs less efficiently in TCRs lacking the CD3 –ITAM. Day
14 fetal thymic lobes of WT and CD3 – ITAM mice were cultured in FTOCs, and analyzed
over time for the generation of thymocytes expressing TCR  (A and B), and CD4 and CD8
(C). A histogram for the TCR  staining on day 7 of the FTOC is shown in panel A, as well as
the gates for distinguishing TCR -hi and TCR -lo cells. A time course for the development
of cells expressing high levels of TCR  is shown in B, and the percentages of DN, DP, and SP
cells on day 7 of the FTOC are shown in C. For SP cells, only those also expressing TCR are
shown. Data are representative of three separate experiments.7 Haks et al.
mutant receptors (Fig. 4 D) raises the question whether ag-
onist ligand can also induce the signals required for positive
and negative selection. We therefore tested whether the
ASNENMDAM epitope could induce positive selection in
DP thymocytes with F5– ITAM  mutant TCRs, as
judged by its ability to induce appearance of CD8 single-
positive (CD8 SP) cells in an overnight culture system,
previously described (41). In this setting, DP thymocytes
from different origins can be exposed to defined ligands
presented by a homogeneous antigen-presenting cell pop-
ulation, such that their ability to undergo the early mani-
festations of selection events can be directly compared. An
example of the actual flow cytometry data of F5– ITAM 
mutant DP thymocytes responding to the agonist AS-
NENMDAM ligand by induction of CD8 SP is shown in
Fig. 5 B.
The results unequivocally show (Fig. 6 A) that this ago-
nist ligand for the F5 TCR can induce phenotypical posi-
tive selection in DP thymocytes from F5– ITAM  mutant
mice in vitro, but important differences between the F5–
WT and F5– ITAM  mutant TCRs remain. First, at least
200-fold more ASNENMDAM peptide is required for in-
ducing a phenotypical positive selection response in DP
cells with F5– ITAM  mutant TCRs, and the maximal
number of CD8 SP cells generated by thymocytes with
F5– ITAM  mutant TCRs never reaches more than 50–
60% of that generated by F5–WT cells (Fig. 6 A). Second,
this pattern of responsiveness (i.e., reduced antigen sensitiv-
ity and lower levels of induced CD8 SP cells) is reproduced
for three ASNENMDAM variants with nonconservative
mutations at the nonanchor residue positions 2 or 8 (Fig. 6
A, top panels). Also a variant peptide with a replacement at
position 1 exhibits this reduced ability to induce positive
selection in F5– ITAM  mutant DP thymocytes (Fig. 6
A, bottom left). Finally, for three additional variant pep-
tides with mutations at position 1, the ability to induce
CD8 SP cells through F5– ITAM  mutant receptors is
completely abrogated (Fig. 6 A, remaining bottom panels;
responsiveness to the non-MHC binding variant ASNAN-
MDAM is shown as a negative control). Thus, we have
identified, among a small panel of seven variants of the AS-
NENMDAM epitope, four with a severely reduced ability
to induce CD8 SP cells in the F5– ITAM  mutant DP
thymocytes (accompanied by a reduced maximal response),
Figure 4. Loss of the CD3 –ITAM in mice with F5 TCRs does not affect
ligand binding and off-rate, nor does it affect CD69 up-regulation and TCR
down-regulation. (A) F5–WT lymph node cells were stimulated with graded con-
centrations of the nominal peptide ASNENMDAM (filled circles) or the negative
control peptide ASNANMDAM mutated in the critical MHC-anchor residue at
position 4 (open circles). After 3 d, proliferation was assessed by pulsing cultures
with [3H]thymidine for 18 h. Data correspond to the mean of triplicate cultures.
(B) Sorted DP thymocytes from 6–8-wk-old F5–WT (white histogram, thick line)
and F5– ITAM  (gray histogram, thin line) mice were analyzed for binding to
H2-Db-ASNENMDAM-tetramers. Note that this analysis is for electronically gated CD69-negative DP cells, whereas the TCR  staining shown in Fig.
2 is for all DP cells. (C) Comparison of the off-rate of H2-Db-ASNENMDAM-tetramers to F5–WT (open circles) and F5– ITAM  mutant TCRs
(filled circles). Fluorescence intensity corresponds to: FIexp   FI0. (D) Purified DP thymocytes of F5–WT (open circles) and F5– ITAM  mice (filled cir-
cles) were incubated overnight in the presence of LEC cells as APCs with the indicated concentrations of the immuno-dominant peptide ASNENMDAM
(left panel) or a negative control peptide ASNANMDAM (right panel). Cells were analyzed for up-regulation of the early activation marker CD69, and
are presented as percentage response (see Materials and Methods). For the actual histograms of CD69 expression, see Fig. 5 A. (E) Sorted DP thymocytes
of F5–WT (open circles) and F5– ITAM  mice (filled circles) were analyzed by flow cytometry for the expression of TCR  in response to exposure of
indicated amounts of H2-Db-ASNENMDAM tetramers for 1 h (left panel) or 5 h (right panel). 100% value corresponds to the mean fluorescence of the
TCR  staining on unstimulated DP thymocytes.8 Thymocyte Selection in Mice Lacking the CD3 –ITAM
and three that are completely unable to do so. Although
these in vitro data represent only the initiation of the posi-
tive selection response, they mirror the observations in the
in situ thymus (see Fig. 1 A), and document that the F5–
 ITAM  mutation severely affects positive selection for
multiple ligands.
Does the CD3 –ITAM mutation also affect the other
cell-fate decision that DP thymocytes make on the basis of
signals from their TCR, i.e., negative selection? One
would predict, on the basis of kinetic models for thy-
mocyte selection, that ligands impaired in induction of pos-
itive selection, would be even less capable of inducing neg-
ative selection signals. Quite in contrast to this prediction
however, we find that ASNENMDAM does induce nega-
tive selection in both F5–WT and F5– ITAM  mutant
DP thymocytes, with completely identical ligand sensitivity
and to the same extent (Fig. 6 B). Furthermore, ASNEN-
MDAM does not stand alone in its ability to induce nega-
tive selection in a normal manner, as also its variants with
replacements at positions 1, 2, and 8 induce negative selec-
tion through F5–WT and F5– ITAM  mutant TCRs
(Fig. 6 B). These experiments therefore uncouple, through
a single ITAM mutation, signals inducing the genetic pro-
gram for negative selection from that inducing positive se-
lection for this TCR.
Distinct Effects of the CD3 –ITAM Mutation on ERK,
JNK, and ZAP70 Activation, and on LAT Phosphorylation.
In search of a molecular explanation for these findings, we
compared the ability of the WT and  ITAM  mutant F5
receptors to activate a number of signaling cascades in re-
sponse to the agonist ligand and cross-linking TCR anti-
bodies. Both genetic and biochemical studies have impli-
cated activation of the Ras/Raf/MEK/ERK cascade in
positive selection (26–35), so we evaluated whether ERK
activation might be impaired as a consequence of this
 ITAM  mutation. Under the short-term culture condi-
tions applied for such signaling studies, a very dramatic ef-
fect of the mutation is observed: the amount of phosphory-
lated ERK that could be detected following ligation of the
TCR by anti-TCR  mAb (Fig. 7 A) is reduced to negligi-
ble levels by loss of the CD3 –ITAM.
We also evaluated phosphorylation of the adaptor pro-
tein LAT, as it represents one of the most upstream media-
tors implicated in positive selection (34, 35) probably due
to its requirement for complete activation of the Ras-ERK
pathway (46, 47). Like activation of ERK, LAT phosphor-
ylation is dramatically impaired in the absence of a signal-
ing-competent CD3  chain (Fig. 7 A). This defect in LAT
phosphorylation corroborates the ERK results. To the ex-
tent that antibody-mediated cross-linking of TCRs ap-
proximates perhaps most closely the conditions triggered
by the intrathymic peptide repertoire (certainly not physi-
cally, but at least in polyclonality), these findings are con-
sistent with the complete absence of positive selection in
the in situ thymus (see Fig. 1 A). Experiments in which
TCR triggering was achieved with ASNENMDAM pep-
tide (Fig. 7 B) are in complete agreement with these anti-
body-mediated TCR-triggering experiments, in that de-
fects in ERK activation and LAT phosphorylation are
again revealed.
Figure 5. CD69 upregulation and induction of CD8 SP thymocytes. Representation of the actual flow cytometry observations from which the per-
centage response data in Figs. 4 D and 6 are derived. Sorted F5– ITAM  DP thymocytes were stimulated overnight in dispersed cultures with graded
concentrations of the agonist peptide ASNENMDAM, and viable cells were stained for (A) CD69 or (B) CD4 versus CD8.9 Haks et al.
In sharp contrast, activation of the JNK cascade is unim-
paired by this mutation (Fig. 7 C). Activation of the JNK
and p38 pathways has been linked to negative selection (18,
30, 36, 37), and the completely overlapping ability of F5–
 ITAM  mutant and F5–WT TCRs to induce JNK acti-
vation is fully consistent with the normal negative selection
phenotype in F5– ITAM  thymocytes (Fig. 6 B). Also
ZAP70 activation (Fig. 7 A) is entirely unaffected by the
Figure 6. F5– ITAM  mutant receptors are fully capable of transmitting signals for negative selection in response to ASNENMDAM, but are im-
paired in triggering signals for positive selection. Purified DP thymocytes of F5–WT (open circles) and F5– ITAM  mice (filled circles) were incubated
overnight in the presence of LEC cells as APCs with the indicated concentrations of the nominal peptide ASNENMDAM and seven of its variants, or
with the null-peptide ASNANMDAM (bottom right panel) as a negative control. Cells were analyzed (A) for the percentage of CD8 SP thymocytes as a
readout system indicative for induction of positive selection or (B) cell death by propidium iodide staining as a readout system indicative for induction of
negative selection. Data shown is presented as the percentage of response calculated as described in Materials and Methods.10 Thymocyte Selection in Mice Lacking the CD3 –ITAM
CD3 –ITAM mutation, leaving to be defined which up-
stream events result in the abrogation of LAT phosphoryla-
tion. Taken together, these findings indicate that absence
of CD3 –ITAM in thymocytes with F5 TCRs selectively
alters ERK activation and LAT phosphorylation, and this
defect may explain the blockade of positive selection in
mice lacking the CD3 –ITAM. This analysis therefore
provides the first genetic evidence that the CD3 –ITAM
contributes in a quantitative or qualitative manner to TCR
signal specification.
Discussion
Our results document that the CD3 – ITAM mutation
destroys the ability of F5 TCRs to be positively selected by
any of the peptides represented among the thymic peptide
repertoire in vivo, and severely reduced its ability to re-
spond to multiple synthetic peptide agonists in vitro. This
mutation also results in considerable impairment in positive
selection in the polyclonal TCR repertoire. These obser-
vations are remarkable for at least three reasons. First, the
CD3 – ITAM mutation is unlikely to affect TCR-ligand
binding, and was in fact shown not to for the nominal
ligand ASNENMDAM for the F5 TCR (see Fig. 4, B and
C). Second, effect of the CD3 – ITAM mutation is lim-
ited to positive selection, as all other hallmarks of TCR re-
sponsiveness in DP thymocytes were not affected i.e.,
CD69 up-regulation, TCR down-regulation, and negative
selection. Finally, in a receptor with 9 additional ITAMs
(i.e., 2 in the CD3   heterodimer, 1 in the CD3   het-
erodimer, and 6 in the CD3   homodimer), redundancy in
ITAM function would have been a reasonable prediction,
certainly on the basis of earlier studies about the amplifica-
tion function of ITAM multiplicity. Instead, these results
suggest that at least for some TCRs, for which the F5
TCR is the prototype, an intact repertoire of CD3-ITAMs
is required for positive selection to occur. Other receptors,
on the other hand, can still undergo positive selection
Figure 7. Activation of LAT and
ERK but not JNK is strongly reduced in
the absence of a signaling deficient
CD3  chain. DP thymocytes from 6–8-
wk-old F5–WT and F5– ITAM  mu-
tant mice were stimulated with cross-
linked anti-TCR  (A) or the agonist
peptide ASNENMDAM and anti-CD28
(B and C). At the indicated times, in-
duction of ERK, LAT, and ZAP70
phosphorylation was assessed by immu-
noblotting of whole-cell lysates or
ZAP70 immunoprecipitates (A and B),
while JNK activity was measured using
an in vitro kinase assay (C). JNK and
ZAP70 experiments were performed
only with anti-TCR . Protein loading
was analyzed by immunoblotting with
anti-ERK, anti-LAT, anti-ZAP70 (A and
B), or anti-JNK (C) mAbs.11 Haks et al.
without the CD3 –ITAM. It will be of interest to define
the particular qualities (affinity, off-rate) that renders a
given TCR sensitive to loss of certain ITAMs. In addition,
it remains to be established how the dramatic effect of the
CD3 – ITAM mutation on positive selection of F5
TCRs is linked to quantitative and/or qualitative changes
in signaling events.
These results complement other studies which addressed
the role of ITAM multiplicity in thymocyte selection (7;
19–21): for CD3 - and CD3 -ITAMs, the data supported
either a quantitative contribution of ITAM diversity in T
cell maturation, or no role at all. The results differ, depen-
dent on the TCR studied. The selective effect of CD3 –
 ITAM on thymocyte selection by F5 TCRs in this study
can be explained either by considering a quantitative con-
tribution of CD3 –ITAMs to TCR signaling that results in
a qualitatively different repertoire, or reflect a unique role
for the CD3 –ITAM in TCR-driven selection. This latter
possibility seems unlikely, as adult mice with the CD3 –
ITAM mutation and a polyclonal TCR repertoire have an
apparently normal positive selection phenotype (see Fig. 1).
At the same time, we also predict that there will be “holes”
in the TCR repertoire of non-TCR transgenic CD3 –
 ITAM mutant mice, as there clearly are multiple TCRs
that are not indifferent to loss of the CD3 –ITAM: a dy-
namic evaluation of T cell development in FTOCs reveals
at least a twofold reduction in the efficiency of positive se-
lection (Fig. 3). These findings are not at variance with the
seemingly normal positive selection phenotype in adult
mice, as in FTOCs, development from only a limited pre-
cursor pool provides a more stringent test of the capacity of
a polyclonal set of precursors to be positively selected. To-
gether, the results indicate that different TCRs interpret
the qualitative contributions to signal discrimination from
ITAMs differently.
Another remarkable finding in the above studies is that
F5– ITAM  mutant receptors cannot identify, in the sea
of thymic peptides they can interact with in vivo, even a
single peptide that induces positive selection, yet positive
selection can be induced (though in a severely “crippled”
manner) by the agonist ligand for the F5 receptor, and by a
number of its variants in vitro. Are these observations at
variance with the observation that positively selecting
ligands normally bear little resemblance to the cognate pep-
tide for a given receptor (48)? It is difficult to answer this
question, in view of the fact that the culture conditions
used for the positive selection experiments probably do not
reflect the peptide concentrations present in the thymic
microenvironment. Nevertheless, it should be noted that
peptide binding and off-rate are not affected by loss of
CD3 –ITAM, nor are early hallmarks of TCR-ligand in-
teractions, such as CD69 up-regulation and TCR down-
regulation (Fig. 4). More importantly, our findings under-
score that the decision for triggering signaling pathways
required for positive selection is not dictated by the binding
kinetics of a given TCR-ligand interaction alone, but also
by intrinsic properties of the TCR-CD3 complex, in this
case, modulated in its cytoplasmic domains by removal of
the CD3 –ITAM.
Two precedents for mutations in the TCR-CD3 com-
plex that regulate positive selection without affecting ligand
binding were reported last year. In one study (35), the
CD3  chain was shown to have a role, independent of its
ITAM, in coupling the TCR to phosphorylation of LAT
and CD3  and activation of ERK, and in induction of pos-
itive selection. In mice expressing mutant TCRs lacking
the TCR  chain connecting peptide domain ( -CPM),
positive selection is also abrogated (34), and this defect was
found to be associated with impaired recruitment to lipid
rafts of activated PTKs Lck and ZAP-70, and of phosphor-
ylated CD3  and LAT. Interestingly, the  -CPM mutation
specifically disrupts association of CD3  with the TCR
complex, providing an explanation for the finding that
both loss of CD3  and loss of  -CPM result in impairment
of activation of the same upstream signaling components,
and that both have a defect in positive selection.
The specific effect of the CD3 – ITAM mutation on
positive selection by the F5 TCR is associated with a selec-
tive defect in activation of the ERK cascade, previously
implicated in positive selection (26–35). JNK activation, on
the other hand, is not affected by the CD3 – ITAM mu-
tation, nor is negative selection, in accordance with the
previously found association between JNK and p38 activa-
tion and negative selection (18, 30, 36, 37). Although these
findings are only correlative, they do suggest that the JNK
and ERK signaling pathways can bifurcate upstream of a
given ITAM. As ERK is a downstream target of Ras, it is
interesting that the most upstream defect associated with
loss of CD3 –ITAM is an almost complete abrogation of
LAT phosphorylation. Phosho-LAT recruits multiple sig-
naling molecules to the plasma membrane, including the
Grb2-Sos complex, such that Sos can then activate Ras (45,
46, 49). Defective LAT phosphorylation may thus result in
an impairment of Ras activation, providing one mechanism
through which ERK activation may have been reduced.
Other possibilities need to be considered, however, as an-
other pathway for Ras activation has been proposed (50):
phospho-LAT also recruits PLC 1 and the Gads-SLP-76
complex, and these appear required for optimal Ras activa-
tion as well (50). Interestingly, the RasGRP has been im-
plicated in this pathway, and RasGRP-deficient mice have
a severe block in positive selection (51). These different
options illustrate that further dissection of how loss of the
CD3 –ITAM affects the very first steps in TCR-induced
phosphorylation and recruitment of signaling proteins to
the “signalosome,” is needed. Nevertheless, we do not ob-
serve any modulations in ZAP70 activation, unlike the
findings in the  -CPM mutants (34), but in keeping with
earlier observations in ZAP70-deficient mice, in which
both positive and negative selection are affected. The posi-
tive selection defects in  -CPM mutant mice (34) and
CD3 -deficient mice (35) are also associated with very
early modulations in TCR signaling, i.e., in recruitment of
phospho-CD3  and phospho-LAT to lipid rafts.12 Thymocyte Selection in Mice Lacking the CD3 –ITAM
Summarizing, the results define one ITAM as a tool for
linking a given TCR to the distinct signaling pathways it
needs to engage in order to trigger paradoxically both neg-
ative and positive selection at the DP checkpoint. It will be
of interest to exploit the present model for searching for
specific downstream events associated with selection. Posi-
tive selection must be associated with activation of specific
genes, different from those promoting negative selection,
either because of triggering of specific sets of transcription
factors, or because the levels of transcription factors trig-
gered by positively selecting signals are different from those
triggered by negative selecting signals. Having now avail-
able a model system that selectively impairs positive selec-
tion while leaving negative selection of DP thymocytes in-
tact, provides the opportunity to search for such events.
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